During the nine months ended December 31, 2019, nonqualified stock options to purchase 230,000 shares were exercised at a strike price of $1.98 per share for total proceeds of $455. No stock options were exercised during the nine months ended December 31, 2018.

During the nine months ended December 31, 2019 and 2018, shareholders made capital contributions of $0 and $245 to FRHC, respectively.

On October 6, 2017, the Company awarded restricted stock grants totaling 3,900,000 shares of its common stock to 16 employees and awarded nonqualified stock options to purchase an aggregate of 360,000 shares of its common stock to two employees. Of the 3,900,000 shares awarded pursuant to the restricted stock grant awards, 1,200,000 shares are subject to two-year vesting conditions and 2,700,000 shares are subject to three-year vesting conditions. All of the nonqualified stock options are subject to three-year vesting conditions. The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $546 and $2,100 during the three and nine months ended December 31, 2019. The Company recorded stock-based compensation expense for restricted stock grants and stock options in the amount of $847 and $2,533 during the three and nine months ended December 31, 2018 respectively.